6 recruiting, 3 terminated. 9 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Recruiting 6, Terminated 3 |
| Phase 2 | 5 | Recruiting 4, Terminated 1 |
Follow Transurethral Resection of Bladder: new trials by email Literature Review of Transurethral Resection of Bladder trials Research Report on Transurethral Resection of Bladder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial Intensity-Modulated Radiation Therapy, Volume Modulated Arc Therapy, Radiosensitizing Agent - Muscle Invasive Bladder Carcinoma, Stage III Bladder Cancer AJCC v8 | Phase 1 / Phase 2 | Recruiting | University of Washington | 12 | 2026-08-20 | 2026-08-25 |
| A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer Bicalutamide, Biopsy Procedure, Biospecimen Collection - Non-Muscle Invasive Bladder Urothelial Carcinoma, Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma | Phase 1 | Recruiting | University of Wisconsin, Madison | 80 | 2026-06-25 | 2026-09-30 |
| Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas Biospecimen Collection, Eflornithine, Lumbar Puncture - Anaplastic Oligodendroglioma, Astrocytoma, IDH-Mutant, Grade 3 | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 33 | 2026-06-23 | 2026-06-24 |
| Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors Ad-hCMV-Flt3L, Ad-hCMV-TK, Biospecimen Collection - Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant, Recurrent Malignant Brain Neoplasm | Phase 1 | Recruiting | University of Michigan Rogel Cancer Center | 11 | 2026-05-22 | 2026-06-15 |
| DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma DOC1021, Tumor resection, pIFN (peginterferon alfa-2a) - Refractory Melanoma | Phase 1 / Phase 2 | Recruiting | Diakonos Oncology Corporation | 35 | 2026-04-06 | 2026-09-09 |
| Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer Enfortumab Vedotin, Pembrolizumab, Intensity Modulated Radiation Therapy (IMRT) - Bladder Cancer, Muscle-Invasive Bladder Carcinoma | Phase 1 / Phase 2 | Recruiting | University of California, San Francisco | 47 | 2025-03-31 | 2026-10-01 |
| FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Head and Neck Squamous Cell Carcinoma | Phase 1 | Terminated | University of Southern California | 1 | 2024-04-01 | 2025-09-16 |
| Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery Cetuximab, Cetuximab-IRDye 800CW, Tumor resection - Brain Neoplasm, Malignant Glioma | Phase 1 / Phase 2 | Terminated | Eben Rosenthal | 3 | 2016-10-01 | 2020-03-31 |
| Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine Heat Shock Protein Peptide Complex-96 (HSPPC-96), Tumor Resection, Radiation - Glioblastoma Multiforme, Astrocytoma, Grade III | Phase 1 | Terminated | Ann & Robert H Lurie Children's Hospital of Chicago | 10 | 2016-07-01 | 2025-02-18 |
Astrocytoma (2) · Brain Neoplasms (2) · Glioblastoma (2) · Glioma (2) · Urinary Bladder Neoplasms (2) · Ependymoma (1) · Lymphoma, Follicular (1) · Melanoma (1) · Oligodendroglioma (1) · Squamous Cell Carcinoma of Head and Neck (1)
Ann & Robert H Lurie Children's Hospital of Chicago (1) · Diakonos Oncology Corporation (1) · Eben Rosenthal (1) · Mayo Clinic (1) · University of California, San Francisco (1) · University of Michigan Rogel Cancer Center (1) · University of Southern California (1) · University of Washington (1) · University of Wisconsin, Madison (1)
United States (9)
Andrea T Franson (1) · Eben Rosenthal, MD (1) · Edward M Messing (1) · Gordon Li, MD (1) · Jacob Thomas, MD (1) · Stewart Goldman, MD (1) · T. Martin Ma, MD, PhD (1) · Terence C. Burns, MD, PhD (1) · Vadim Koshkin, MD (1)
P30CA014089 (1), P30CA014520 (1), P30CA124435 (1), UG1CA242635 (1)